Toggle light / dark theme

Game-Changing Blood Pressure Drug Works for Patients Not Controlled by Standard Treatments

Blood pressure is one of the most common health problems worldwide, yet it remains difficult to control for many patients even with daily medication. New research from the United Kingdom suggests a different approach could help. Scientists report that a treatment given just twice a year may offer sustained blood pressure reductions for people whose hypertension has proven hard to manage.

The findings come from a large international clinical trial published in JAMA and led by researchers at Queen Mary University of London. The study focused on a long-acting injectable therapy designed to work alongside existing blood pressure medications rather than replace them.

Neuralink’s Brain Chip: How It Works and What It Means

Elon Musk recently announced that Neuralink, his company aiming to revolutionize brain-computer interfaces (BCIs), has successfully implanted a brain chip in a human for the first time. The implantation of the device, called “the Link,” represents a leap forward in the realm of BCIs, which record and decode brain activity, that may allow for new innovations in health care, communication, and cognitive abilities.

Though limited information on the technology is available and Neuralink’s claims have not been independently verified, here’s a look at the Link, its functionality, and the potential implications of this groundbreaking innovation.

Prenatal exposure to air pollution associated with lower cognitive performance in early childhood

The prenatal period is a critical window for brain development, yet few studies have examined the impact of air pollution exposure during pregnancy on child cognition. A new study led by the Barcelona Institute for Global Health (ISGlobal), in collaboration with the University of Barcelona (UB), shows that prenatal exposure to pollution is associated with lower cognitive performance in newborns.

These findings highlight the importance of reducing air pollution exposure, especially during pregnancy, to protect neurodevelopment.

The study, published in Environmental Pollution, included data from 168 mother-child pairs participating in the BiSC (Barcelona Life Study Cohort) project, conducted in Barcelona between 2018 and 2023.

Brewing possibilities: Using caffeine to edit gene expression

What if a cup of coffee could help treat cancer? Researchers at the Texas A&M Health Institute of Biosciences and Technology believe it’s possible. By combining caffeine with the use of CRISPR—a gene-editing tool known as clustered regularly interspaced short palindromic repeats—scientists are unlocking new treatments for long-term diseases, like cancer and diabetes, using a strategy known as chemogenetics.

The work is published in the journal Chemical Science.

Yubin Zhou, professor and director of the Center for Translational Cancer Research at the Institute of Biosciences and Technology, specializes in utilizing groundbreaking tools and technology to study medicine at the cellular, epigenetic and genetic levels. Throughout his career and over 180 publications, he has sought answers to medical questions by using highly advanced tools like CRISPR and chemogenetic control systems.

Airports reintroduce Covid-style checks after deadly Nipah virus outbreak in India

From the article:

Nipah virus outbreaks have been associated with a high death rate in the past, with fatality levels reported between 40 and 75 per cent depending on the outbreak and the viral strain involved.

The virus has been documented in Bangladesh, India, Malaysia, the Philippines and Singapore, with Bangladesh recording the highest number of 341 cases and 241 deaths, according to the International Society for Infectious Disease.


Airports across parts of Asia have begun tightening health surveillance and travel screening after an outbreak of Nipah virus in an Indian state.

Thailand, Nepal and Taiwan are among the countries and territories that have stepped up precautionary measures after five Nipah virus cases were confirmed in India’s West Bengal.

Nipah is a zoonotic disease that mainly spreads to humans from infected pigs and bats, but can also be passed on through close person-to-person contact.

New Drug Slashes Dangerous Blood Fats by Nearly 40% in First Human Trial

When we eat, the body turns surplus calories into molecules called “triglycerides”, especially when those calories come from carbs, sugar, fats, and alcohol. Triglycerides are a type of fat or “lipid”, and the body stores them in fat cells to use as fuel between meals.

However, too much of this fat can become harmful. High triglyceride levels can lead to “hypertriglyceridemia” (“excess triglycerides in the blood”), a condition tied to a much higher risk of heart disease, stroke, and pancreatitis. That is why people are widely encouraged to support healthy triglyceride levels through diet and exercise, while more severe cases may require medication.

Scientists Uncover Potential “Two-in-One” Treatment for Diabetes and Heart Disease

Earlier work linked the experimental drug ‘IC7Fc’ to improvements in type 2 diabetes, and new research now points to a possible role in cardiovascular health as well. Scientists report that the compound may lower the risk of heart disease by reducing harmful cholesterol in the bloodstream and calming inflammatory activity that damages blood vessels over time.

The findings come from a preclinical study published in Science Advances, led by researchers at Leiden University Medical Centre in the Netherlands in collaboration with Monash University and other international partners.

In experiments involving mice genetically predisposed to heart disease, treatment with IC7Fc led to clear reductions in blood fat (triglycerides) and cholesterol, markers closely linked to the development of cardiovascular complications.

Burden of Central Nervous System Cancer in the United States

While incidence rates for central nervous system cancer remained stable from 1990 to 2021, both mortality and disability-adjusted life-years (DALYs) declined. Disparities by geography, age, sex, and sociodemographic status highlight needs for targeted health policy reforms and resource redistribution.


Findings In this cross-sectional study, analysis of the Global Burden of Disease Study 2021 data on US CNS cancers revealed that although the incidence rate remained relatively stable, both disability-adjusted life-years and mortality rates declined. However, substantial disparities persisted across geographical location, age, sex, and sociodemographic profile.

Meaning The persistent disparity in CNS cancer burden highlights the urgent need to reevaluate public health policies and redistribute health care resources to better support marginalized and underserved populations.

/* */